Aberdeen Group
GMAB icon

Aberdeen Group’s Genmab GMAB Stock Holding History

Aberdeen Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.95M Buy
+110,671
New +$3.5M 0.01% 780
2024
Q2 		– Sell
-49,797
Closed -$1.49M – 958
2024
Q1 		$1.49M Buy
+49,797
New +$1.46M ﹤0.01% 800

Other funds holding GMAB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return
Eagle Global Advisors
Eagle Global Advisors Houston, Texas $3.02B AUM 27.86% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Legacy Wealth Asset Management
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return

Aberdeen Group's GMAB Position: Q3 2026 in Review

Aberdeen Group opened a new position in Genmab (GMAB) in Q3 2026: 110,671 shares worth $3.95M. The stake represents 0.01% of the portfolio and ranks #780 among its holdings. This is a return to the name: Aberdeen Group previously reported a position in GMAB as recently as Q1 2024.

Aberdeen Group first reported a position in GMAB in Q1 2024 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

  • Aberdeen Group held 110,671 shares of Genmab worth $3.95M as of Q3 2026.
  • Genmab was a new Aberdeen Group position in Q3 2026.
  • Genmab made up 0.01% of Aberdeen Group's portfolio in Q3 2026, its #780 holding.
  • Aberdeen Group first reported a position in Genmab in Q1 2024 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on Aberdeen Group's 13F filing for Q3 2026, filed 6 Nov 2026.